Guidelines for Cannabis Dosing in Older Adults
Older adults cannabis dosing guidelines are essential for safe and effective use in this growing population. Age-related changes affect cannabinoid metabolism and increase drug interaction risks. Clinicians should tailor dosing and monitor older patients…
New Insights on Cannabis Liver Interactions from Recent Study
Cannabis liver interactions are critical for understanding hepatic metabolism and drug safety. This study highlights how cannabis compounds affect liver enzyme systems. Clinicians should monitor liver function closely when patients use cannabis…
Alcohol as a Novel Trigger for Cannabis Hyperemesis Syndrome
Alcohol cannabis hyperemesis trigger is emerging as a novel factor in cannabis hyperemesis syndrome (CHS). This condition affects chronic cannabis users with cyclic nausea and vomiting. Understanding alcohol's role may improve clinical counseling and…
Cannabinoid Clinical Trials: CBD and Cortical Excitability Insights
This clinical trial investigates CBD antiseizure pharmacokinetic interaction and its effects on cortical excitability. Results indicate CBD alone does not alter cortical excitability in healthy men. The findings highlight the importance of drug…
Endocannabinoid System Research: CBD & Cortical Excitability
In a controlled crossover trial, cannabidiol lacks direct effect on cortical excitability compared to placebo. This suggests CBD’s anti-seizure benefits depend on interactions with medications like clobazam. Clinicians should consider this when…